Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: greenbaum la. Kidney Int. 2023 Jul;104(1):205. doi: 10.1016/j.kint.2023.04.010. Kidney Int. 2023. PMID: 37349053 Free article. No abstract available.
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum.
Kavanagh D, Ardissino G, Brocklebank V, Bouwmeester RN, Bagga A, Ter Heine R, Johnson S, Licht C, Ma ALT, Noris M, Praga M, Rondeau E, Sinha A, Smith RJH, Sheerin NS, Trimarchi H, Wetzels JFM, Vivarelli M, Van de Kar NCAJ, Greenbaum LA; Forum Participants. Kavanagh D, et al. Among authors: greenbaum la. Kidney Int. 2024 Dec;106(6):1038-1050. doi: 10.1016/j.kint.2024.09.012. Epub 2024 Oct 10. Kidney Int. 2024. PMID: 39395628 Free article.
Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach.
Bhayana S, Zhao Y, Merchant M, Cummins T, Dougherty JA, Kamigaki Y, Pathmasiri W, McRitchie S, Mariani LH, Sumner S, Klein JB, Li L, Smoyer WE; Pediatric Nephrology Research Consortium. Bhayana S, et al. Kidney Int Rep. 2023 Mar 23;8(6):1239-1254. doi: 10.1016/j.ekir.2023.03.015. eCollection 2023 Jun. Kidney Int Rep. 2023. PMID: 37284673 Free PMC article.
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.
Daniel-Fischer L, Antlanger M, Cejka D, Eller K, Gauckler P, Odler B, Rudnicki M, Säemann MD, Schmidt A, Sunder-Plassmann G, Wiesholzer M, Windpessl M, Zitt E, Koenig F, Greenbaum LA, Kronbichler A, Aufricht C. Daniel-Fischer L, et al. Among authors: greenbaum la. Kidney Int Rep. 2023 Nov 3;9(2):478-481. doi: 10.1016/j.ekir.2023.10.027. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344717 Free PMC article. No abstract available.
Glucocorticoid Exposure and Infection in Children and Adults With Glomerular Disease: Findings From the Cure Glomerulonephropathy Study.
Glenn DA, Andrews C, Liu Q, Zee J, Mansfield S, Smith A, O'Shaughnessy MM, Bomback A, Gibson K, Greenbaum LA, Falk RJ, Hogan SL, Mottl A, Denburg MR; CureGN Consortium. Glenn DA, et al. Among authors: greenbaum la. Am J Kidney Dis. 2024 Dec 18:S0272-6386(24)01123-5. doi: 10.1053/j.ajkd.2024.10.008. Online ahead of print. Am J Kidney Dis. 2024. PMID: 39706245 No abstract available.
183 results